| scholarly article | Q13442814 |
| P50 | author | Dong-Ho Nahm | Q84969330 |
| P2093 | author name string | Jin-Woo Lee | |
| Gil-Soon Choi | |||
| Jeong-Eun Kim | |||
| Myoung-Eun Kim | |||
| Joon-Mo Sung | |||
| P2860 | cites work | Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. | Q34480913 |
| Global strategy for asthma management and prevention: GINA executive summary. | Q34731997 | ||
| Induction of atopic dermatitis by inhalation of house dust mite | Q34733034 | ||
| Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper | Q34754637 | ||
| Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report | Q36525105 | ||
| Accelerated immunotherapy schedules: review of efficacy and safety | Q36579814 | ||
| Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. | Q36734980 | ||
| Allergen specific immunotherapy for atopic dermatitis | Q36995977 | ||
| Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy | Q37392631 | ||
| Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis | Q43558341 | ||
| Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats | Q46540032 | ||
| Compliance with allergen immunotherapy. | Q51051892 | ||
| Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. | Q52648220 | ||
| Allergen immunotherapy: a practice parameter third update. | Q52712682 | ||
| Guidelines of care for atopic dermatitis | Q61962654 | ||
| Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis | Q70811486 | ||
| The role of dust mite allergens in atopic dermatitis | Q71822962 | ||
| Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts | Q72852389 | ||
| Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts | Q77762815 | ||
| Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts | Q79947414 | ||
| Venom immunotherapy: aqueous vs aluminium hydroxide adsorbed extracts | Q80096878 | ||
| Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts | Q82065257 | ||
| Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study | Q82247224 | ||
| Side-effects of allergen-specific immunotherapy: a prospective multi-centre study | Q82654593 | ||
| P433 | issue | 9 | |
| P921 | main subject | immunotherapy | Q1427096 |
| Dermatophagoides pteronyssinus | Q4573411 | ||
| P304 | page(s) | 1159-1164 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Journal of Korean Medical Science | Q24039955 |
| P1476 | title | Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis | |
| P478 | volume | 26 |
| Q38111236 | Accelerated immunotherapy schedules |
| Q41851865 | Autologous immunoglobulin therapy in patients with severe recalcitrant atopic dermatitis: a preliminary report |
| Q37231881 | Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis |
| Q37503322 | Environmental assessment and exposure control of dust mites: a practice parameter |
| Q90270996 | Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis |
| Q33770349 | Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors |
| Q35648296 | Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin |
Search more.